Parallax Volatility Advisers, L.P. Bristol Myers Squibb CO Transaction History
Parallax Volatility Advisers, L.P.
- $42.9 Billion
- Q2 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 47,237 shares of BMY stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
47,237
Previous 15,000
214.91%
Holding current value
$2.15 Million
Previous $914,000
139.17%
% of portfolio
0.01%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,664Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.89 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.23 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.93 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.32 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.23 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...